Manufacturing IoT
IoT in New Jersey's Pharmaceutical Industry
Published by IOT New Jersey Research & Editorial Team

- Why the Industry Is a Natural Fit
- The Value Chain, Step by Step
- Research and Development Labs
- Manufacturing and the Data Integrity Question
- Packaging, Serialization, and Traceability
- What Recent Investment Signals
- Contract Partners and Shared Responsibility
- Energy, Water, and Sustainability
- Cold Storage and the Biologics Shift
- From Pilot to Plant-Wide Program
- Challenges Specific to Pharma
- A Roadmap for Companies of Different Sizes
- What to Ask an IoT Vendor Serving a Regulated Plant
- Measuring Success
- Where to Begin
New Jersey's pharmaceutical industry is often described by its names and its headcount. It is more useful to describe it by its processes: laboratories that develop molecules, pilot plants that scale them, commercial plants that make them under tight controls, packaging lines that serialize every unit, warehouses and trailers that carry them, and clinics and homes where they end up. IoT touches every step, and the opportunity is different at each one. This guide maps where connected sensors and data systems add value across the industry, what recent investment suggests about where demand is heading, and how companies of different sizes can approach adoption. It works as a hub for the more detailed pieces we have written on specific topics.
Why the Industry Is a Natural Fit
Pharmaceutical production is a measurement-heavy business by necessity. Products must be made within defined parameters, environments must stay within limits, records must be accurate and complete, and any deviation must be investigated. Those requirements already produce enormous amounts of data, much of it still captured by hand or in disconnected systems. IoT does not introduce measurement to this industry. It makes measurement continuous, automatic, and connected, which is why interest in Pharma 4.0 and IoT keeps growing.
The Value Chain, Step by Step
| Stage | What IoT Adds | Where to Read More |
|---|---|---|
| Research and process development | Instrument connectivity, freezer and incubator monitoring, sample tracking | This article |
| Manufacturing | Process sensors, equipment health monitoring, batch data capture | IoT in pharmaceutical manufacturing |
| Cleanrooms and controlled areas | Continuous particle, pressure, temperature, and humidity monitoring | connected cleanrooms |
| Maintenance and reliability | Vibration, temperature, and current sensing for early fault warning | predictive maintenance in pharmaceutical manufacturing |
| Packaging and serialization | Line monitoring, unit-level tracking, reject analysis | This article |
| Warehousing and cold chain | Temperature and location monitoring from dock to destination | connected cold chains |
| Distribution and logistics | Real-time shipment visibility and handoff records | connected freight |
| Patients and providers | Connected devices, remote monitoring, adherence data | connected care |
Research and Development Labs
Laboratories hold some of the most valuable material in a company: cell lines, reference standards, and samples that cannot be recreated. Freezers, refrigerators, and incubators fail quietly, and a single overnight failure can destroy years of work. Connected temperature and door sensors with alerts to a phone give early warning, and continuous logs support quality records. Instrument connectivity matters too. Many lab instruments still export results through manual transfer, which creates delays and transcription risk. Connecting them to a data system saves scientist time and improves record integrity.
Manufacturing and the Data Integrity Question
Regulators expect records to be attributable, legible, contemporaneous, original, and accurate, a set of principles often summarized as ALCOA, with extensions that add completeness, consistency, endurance, and availability. IoT can strengthen compliance by capturing data automatically at the source, time-stamping it, and protecting it from alteration. It can also weaken compliance if poorly designed, for example when sensor data is stored in a system that lacks access controls or an audit trail. Any connected device that feeds a regulated record should be part of a validated system, with documentation of how it is calibrated, how data flows, and how changes are controlled. The practical routes are covered in IoT environmental monitoring in pharmaceutical plants and how New Jersey pharma plants use sensors for environmental monitoring.
Packaging, Serialization, and Traceability
Federal drug supply chain law requires unit-level tracing as products move between manufacturers, distributors, and dispensers, with requirements phasing in over several years. Packaging lines therefore generate identifiers that must be captured, verified, and shared accurately. Line sensors and vision systems check codes, reject faulty units, and record exceptions, and connected data lets quality teams see patterns, such as a particular line or shift producing more rejects. Companies should confirm the current status of each requirement for their role in the supply chain, since deadlines and exemptions have changed over time.
What Recent Investment Signals
New Jersey's pharmaceutical footprint is expanding, which shapes the market for connected technology. BeOne Medicines announced a $300 million expansion in Hopewell in July 2026 that adds a 145,000-square-foot building for biologics and small molecules, including drug product manufacturing and packaging. Hovione opened a $100 million, 31,000-square-foot plant in East Windsor in September 2026 that doubles its commercial spray drying capacity. Both are described in our New Jersey IoT news roundup. New plants tend to specify monitoring and data systems from the start, and the combination of biologics, small molecules, and packaging under one roof creates varied requirements, from cold storage to dry powder handling.
Contract Partners and Shared Responsibility
Much of the industry's work passes through contract development and manufacturing organizations, testing laboratories, packagers, and logistics providers. Quality is shared, and so is the data. A sponsor that sends a product to a contract site needs to know that storage conditions, process parameters, and shipping temperatures are monitored to agreed standards, and that records can be shared quickly during an investigation. Connected monitoring that both parties can see turns quality agreements from promises into evidence. Companies setting up new partnerships should write the monitoring expectations, the data format, and the alert contacts into the agreement, not leave them to be negotiated after a deviation occurs.
Energy, Water, and Sustainability
Pharmaceutical plants are heavy users of energy for heating, cooling, and air handling, since controlled environments need constant ventilation and filtration. Water systems feed production and cleaning. Submetering and monitoring help plants find waste without compromising controlled conditions, for example by tuning air change rates in unoccupied rooms within validated limits. The approach parallels the cost control methods in IoT energy management for New Jersey businesses, and many companies now track these figures to support corporate sustainability reporting as well as cost goals.
Cold Storage and the Biologics Shift
As more production moves toward biologics, storage and handling conditions become tighter. Many biologic products require refrigerated or frozen storage, and some need ultra-cold conditions, which raises the stakes for every freezer, shipper, and loading dock. Connected temperature monitoring with redundant alerts and backup power status is no longer an extra for these products. It is part of the quality system. Sites that handle both small molecule and biologic products need to design monitoring for very different conditions in the same building, and operators should map which areas need which level of protection before choosing devices.
From Pilot to Plant-Wide Program
Many pilots succeed and then stall, because nobody planned for scale. Before a pilot ends, decide who owns the system, who responds to alerts, how new devices are qualified, how data will be stored and for how long, and what budget supports it. Write short standard operating procedures for each. Pick a naming scheme for devices and locations early, since inconsistent names make data hard to use later. A program that treats these basics seriously can grow from a freezer pilot into plant-wide monitoring without having to be rebuilt.
Challenges Specific to Pharma
Validation Burden
Every new system in a regulated environment must be qualified, which takes time and effort. The right response is not to avoid change but to choose technology with good documentation, vendor support for qualification, and a clear approach to change control.
Legacy Equipment
Many plants run equipment that predates connectivity. Retrofit sensors that observe without controlling can add visibility without touching a validated process, a practice described in IoT retrofit approaches for older New Jersey plants and in industrial IoT sensors in New Jersey.
Operational Technology Security
Connected process equipment must be secured against unauthorized access. Network segmentation, access control, and monitoring should be part of the design, consistent with the principles in connected medical device security.
Skills
The workforce needs people who understand both process science and data systems. Many companies pair process engineers with data engineers on small projects so each side learns the other's language.
A Roadmap for Companies of Different Sizes
- Startups and small developers: begin with monitoring of freezers, storage, and shipments, since failures there are costly and the technology is simple.
- Mid-sized manufacturers and contract organizations: add environmental monitoring and equipment health sensing on the most critical lines, and connect data to existing quality systems.
- Large manufacturers: build an enterprise data layer, standardize sensor choices across sites, and use predictive analytics on equipment fleets, as described in predictive maintenance in New Jersey pharma and chemical plants and industrial IoT across New Jersey.
What to Ask an IoT Vendor Serving a Regulated Plant
- Can you provide documentation to support qualification, including calibration procedures and traceability?
- How does your system handle audit trails, user access, and electronic records?
- What is your process for software updates, and how do you support change control?
- Can the system operate through network interruptions without losing data?
- How is data protected in transit and at rest, and who at your company can access it?
- What is the expected life of the sensors, and what is the replacement plan?
Measuring Success
- Fewer unplanned equipment stoppages and shorter repairs.
- Fewer environmental excursions and faster closure of deviations.
- Less time spent on manual data entry and record review.
- Reduced product loss from storage and shipping failures.
- Faster batch record review and release.
Where to Begin
Pick one pain point that is expensive, frequent, and measurable, such as freezer failures or environmental excursions in one area. Define the success measure before buying anything. Involve quality and validation staff from the first meeting. Run a small pilot, document it thoroughly, and use the results to decide the next step. Companies that follow this path build trust within the organization, and trust is the main ingredient for larger programs. The wider guide to smart manufacturing in New Jersey offers further context for plants outside pharma.
